Jeff Yass’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6M Buy
521,500
+208,300
+67% +$17.6M ﹤0.01% 1878
2026
Q1
$31.1M Buy
313,200
+96,100
+44% +$12.5M ﹤0.01% 1702
2025
Q4
$26.4M Sell
217,100
-137,000
-39% -$17.2M ﹤0.01% 1933
2025
Q3
$39.7M Buy
354,100
+94,800
+37% +$11.1M ﹤0.01% 1524
2025
Q2
$34.7M Buy
259,300
+21,200
+9% +$2.33M ﹤0.01% 1462
2025
Q1
$16M Sell
238,100
-148,900
-38% -$10.2M ﹤0.01% 1960
2024
Q4
$24.1M Buy
387,000
+289,800
+298% +$27M ﹤0.01% 1707
2024
Q3
$15.3M Buy
97,200
+47,600
+96% +$7.33M ﹤0.01% 2106
2024
Q2
$7.47M Sell
49,600
-54,600
-52% -$6.55M ﹤0.01% 2849
2024
Q1
$7.7M Buy
104,200
+72,700
+231% +$5.99M ﹤0.01% 2998
2023
Q4
$2.49M Buy
31,500
+17,800
+130% +$1.07M ﹤0.01% 4923
2023
Q3
$750K Sell
13,700
-35,200
-72% -$2.53M ﹤0.01% 7292
2023
Q2
$4.11M Sell
48,900
-900
-2% -$68.9K ﹤0.01% 3846
2023
Q1
$3.77M Buy
49,800
+39,100
+365% +$2.7M ﹤0.01% 3887
2022
Q4
$660K Sell
10,700
-16,500
-61% -$877K ﹤0.01% 7157
2022
Q3
$1.14M Buy
+27,200
New +$1.18M ﹤0.01% 6305
2022
Q2
Sell
-7,500
Closed -$202K 13942
2022
Q1
$202K Buy
+7,500
New +$134K ﹤0.01% 11217
2021
Q4
Sell
-41,000
Closed -$1.36M 13912
2021
Q3
$1.36M Sell
41,000
-70,400
-63% -$2.15M ﹤0.01% 6752
2021
Q2
$3.7M Buy
111,400
+24,300
+28% +$673K ﹤0.01% 4601
2021
Q1
$3.61M Buy
87,100
+68,100
+358% +$2.1M ﹤0.01% 4554
2020
Q4
$378K Buy
+19,000
New +$281K ﹤0.01% 8839

Other funds holding TMDX

Jeff Yass's TMDX Position: Q2 2026 in Review

Jeff Yass increased its Transmedics (TMDX) stake by 91% in Q2 2026, buying an estimated $10.3M and bringing the position to 255,398 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Jeff Yass first reported a position in TMDX in Q3 2020 and has held it in 19 quarters since. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Jeff Yass held 255,398 shares of Transmedics worth $17M as of Q2 2026.
  • Jeff Yass bought 121,523 Transmedics shares in Q2 2026, an estimated $10.3M.
  • Transmedics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #2650 holding.
  • Jeff Yass first reported a position in Transmedics in Q3 2020 and has held it in 19 quarters since.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.